Hospital infection immunotherapy developer Aridis files for $34.5M IPOAllbiopro2018-07-20T10:22:37+09:007월 20th, 2018|
Novartis pays €95M to bag dermatitis drug from Galapagos, MorphoSysAllbiopro2018-07-20T10:22:13+09:007월 20th, 2018|
Stripped-down Vical ‘considering options’ after pipeline woesAllbiopro2018-07-20T10:21:48+09:007월 20th, 2018|
IFM Therapeutics’ inflammation-focused subsidiary debuts with $31MAllbiopro2018-07-20T10:21:22+09:007월 20th, 2018|
Novartis nabs much-needed new nod for slow-growing breast cancer drug KisqaliAllbiopro2018-07-20T10:20:58+09:007월 20th, 2018|
FDA chief Gottlieb blames drugmakers for ‘anemic’ biosimilar marketAllbiopro2018-07-20T10:20:34+09:007월 20th, 2018|
FDA targets price-gouging drugmakers with plan to import rival productsAllbiopro2018-07-20T10:20:10+09:007월 20th, 2018|
Janssen wins FDA nod for Symtuza but the once-daily HIV drug must now find its place in the marketAllbiopro2018-07-20T10:19:45+09:007월 20th, 2018|
FDA Invites Comment on New Exposure Limits for CadmiumAllbiopro2018-07-20T10:18:58+09:007월 20th, 2018|
FDA Sends Warning Letter to California OTC ManufacturerAllbiopro2018-07-20T10:18:34+09:007월 20th, 2018|
Olfactory receptors have more functions than merely smell perceptionAllbiopro2018-07-20T10:18:10+09:007월 20th, 2018|
New cost-effective instrument measures molecular dynamics on a picosecond timescaleAllbiopro2018-07-20T10:17:45+09:007월 20th, 2018|
Study demonstrates impact of temperature on mitochondrial DNA evolutionAllbiopro2018-07-20T10:16:56+09:007월 20th, 2018|
Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings Institution on the release of the FDA’s Biosimilars Action PlanAllbiopro2018-07-19T20:53:30+09:007월 19th, 2018|
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiencyAllbiopro2018-07-19T11:21:31+09:007월 19th, 2018|
